Načítá se...
ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer
Because traditional treatment strategies for advanced gastrointestinal (GI) cancers often have a limited therapeutic effect, immunotherapy could be a viable approach for the therapy of advanced GI cancers, considering the recent success of immunotherapy in treating various refractory malignancies, i...
Uloženo v:
| Vydáno v: | Cells |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6678467/ https://ncbi.nlm.nih.gov/pubmed/31277418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8070678 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|